BofA reiterates Celsius stock Buy rating amid Texas probe

Celsius Holdings fell more than 6% after Texas Attorney General Ken Paxton launched an investigation into Alani Nu’s marketing practices aimed at teens and children, potentially implicating the Texas Deceptive Trade Practices Act. BofA Securities reiterated a Buy rating and $55 price target despite the probe, and UBS also maintained a Buy with the same target. The stock is trading at $27.72, near its 52-week low of $27.66, even after Q1 2026 EPS of $0.41 beat the $0.30 consensus on revenue of $783 million versus $763.07 million expected.

Analysis

The market is treating this as a headline risk event, but the real issue is distribution of probability across jurisdictions. A Texas probe rarely stays local in consumer categories with youth-facing branding; it can become a template for copycat AGs, school-district pressure, and retailer compliance reviews over the next 1-3 quarters. That matters because CELH’s valuation still embeds a clean growth story, while regulatory overhangs tend to compress multiples before any actual fine or injunction arrives.

Second-order impact is less about fines and more about channel friction. Even if the legal case is weak, big-box and convenience retailers tend to de-risk by reducing promo intensity, tightening merchandising language, or delaying shelf resets; that can show up first in slower velocity and weaker display support, not in reported revenue. The brand mix also matters: any product line that leans younger in aesthetics becomes a liability for the broader platform, forcing a corporate-level tradeoff between growth and compliance costs.

The contrarian read is that the move may be partially overdone if investors are extrapolating a structural demand hit from what is still a legal-process headline. The stock is already near prior lows, so incremental bad news may have diminishing downside unless there is evidence of retailer pushback or a multistate escalation. Near-term upside would come from management quickly reframing marketing controls and if sell-side confidence remains intact, but the cleaner asymmetry is on the downside over the next 1-2 months if this expands beyond Texas.

Key Decisions for Investors

• Short CELH on strength into any relief bounce over the next 1-2 weeks; use tight risk controls above recent breakdown levels. Risk/reward favors a 1.5-2.0x downside capture if the headline develops into broader state scrutiny.
• Buy CELH put spreads 1-3 months out to express a capped-risk regulatory overhang view. Favor strikes centered just below the current spot range to profit from another 10-15% re-rate if retailer or legal commentary turns adverse.
• Pair trade: long larger beverage/consumer staples names with cleaner regulatory profiles vs short CELH for 1-2 quarters. The thesis is multiple compression on CELH from compliance risk, while the long leg benefits from any rotation out of high-beta growth.
• If management announces explicit marketing remediation and no further jurisdictions join within 30-45 days, cover short exposure aggressively; the stock could snap back quickly because the first move is usually headline-driven rather than fundamentals-driven.